Rock Springs Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
10
- Investments
-
169
- Portfolio
-
30
- Exits
-
112
Rock Springs Capital General Information
Company Description
Founded in 2013, Rock Springs Capital is a venture capital investment firm based in Baltimore, Maryland. The firm seeks to invest in companies operating in the healthcare and healthcare-related sectors.
Business Details
Website
www.rockspringscapital.comYear Founded
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- 650 South Exeter Street
- Suite 1070
- Baltimore, MD 21202
- United States
Rock Springs Capital Investments (169)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Marea | 17-Sep-2026 | PIPE | Biotechnology | Clinical Trials - Phase 2 | ||
| Gossamer Bio | 24-Aug-2026 | Drug Discovery | Generating Revenue | |||
| Abcuro | 14-Aug-2026 | Drug Discovery | Clinical Trials - Phase 3 | |||
| City Therapeutics | 04-Jun-2026 | Drug Discovery | Generating Revenue/Not Profitable | |||
| Parabilis Medicines | 06-Jan-2026 | Drug Discovery | Generating Revenue/Not Profitable | |||
| Hemab Therapeutics Holdings | 27-Oct-2025 | Holding Companies | Generating Revenue | |||
| Talphera | 10-Sep-2025 | Drug Discovery | Generating Revenue | |||
| Treeline Biosciences Holdings | 01-Sep-2025 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Avalyn Pharma | 22-Jul-2025 | Later Stage VC | Drug Discovery | Generating Revenue | ||
| Aclaris Therapeutics | 25-Mar-2025 | PIPE | Drug Discovery | Generating Revenue/Not Profitable |
Rock Springs Capital Exits (112)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Simcha Therapeutics | 26-Oct-2026 | Out of Business | |
| Bolt Biotherapeutics | 23-Oct-2026 | ||
| City Therapeutics | 15-Oct-2026 | ||
| Latigo Bio | 06-Aug-2026 | ||
| Freenome | 20-Jul-2026 | ||
| Parabilis Medicines | 10-Jun-2026 | ||
| Hemab Therapeutics Holdings | 01-May-2026 | ||
| Avalyn Pharma | 30-Apr-2026 | ||
| Spruce Biosciences | 20-Apr-2026 | Public Investment 2nd Offering | |
| Caris Life Sciences | 17-Jun-2025 | IPO |
Rock Springs Capital Investments by Industry, Year, and Region
Rock Springs Capital Co-Investors (170)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| RA Capital Management | 5 |
|
|
||
| ARCH Venture Partners |
|
|
|||
| Foresite Capital |
|
|
|||
| Invus (Private Equity) |
|
|
|||
| T. Rowe Price Group |
|
|
Rock Springs Capital FAQs
-
What is Rock Springs Capital?
Founded in 2013, Rock Springs Capital is a venture capital investment firm based in Baltimore, Maryland.
-
When was Rock Springs Capital founded?
Rock Springs Capital was founded in 2013.
-
Where is Rock Springs Capital headquartered?
Rock Springs Capital is headquartered in Baltimore, MD.
-
What is Rock Springs Capital's total asset value?
Rock Springs Capital has around in total assets under management.
-
How many investments has Rock Springs Capital made?
Rock Springs Capital has made 169 investments.
-
What has Rock Springs Capital invested in?
Rock Springs Capital has made numerous investments in companies like Marea, Gossamer Bio, and Abcuro within the Biotechnology and Drug Discovery industries.
-
What has Rock Springs Capital invested in recently?
Rock Springs Capital's latest investment was on 17-Sep-2026 in Marea, a company within the Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process